[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Sleep Aids in Singapore

October 2023 | 21 pages | ID: S0859A3A57FEN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The pandemic brought about a lot of interest in the topic of immunity in the consumer health industry. Many pharmaceutical companies, including the renowned French company Sanofi, have started establishing vaccine facilities to combat future pandemics. Sanofi opened a vaccine facility in Singapore in April 2022, joining other global pharmaceutical players in this endeavour. The increased focus on immunity in Singapore has raised concerns about sleep duration amongst its residents. A survey condu...

Euromonitor International's Sleep Aids in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Sleep Aids market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
SLEEP AIDS IN SINGAPORE
KEY DATA FINDINGS
2023 DEVELOPMENTS
Subject of immunity sparks consumers’ interest in sleep sufficiency
Melatonin and vitamin B6 remain the most popular ingredients for sleep aids
Preference for herbal/traditional formulations increases in sleep aids
PROSPECTS AND OPPORTUNITIES
Rise in cases of sleep apnoea may limit demand for sleep aids
Consumers may find better sleep with multipurpose vitamins and dietary supplements
Growing interest in mental health may resolve sleep problems holistically
CATEGORY DATA
Table 1 Sales of Sleep Aids: Value 2018-2023
Table 2 Sales of Sleep Aids: % Value Growth 2018-2023
Table 3 NBO Company Shares of Sleep Aids: % Value 2019-2023
Table 4 LBN Brand Shares of Sleep Aids: % Value 2020-2023
Table 5 Forecast Sales of Sleep Aids: Value 2023-2028
Table 6 Forecast Sales of Sleep Aids: % Value Growth 2023-2028
CONSUMER HEALTH IN SINGAPORE
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2018-2023
Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources


More Publications